Advertisement

Pediatric Nephrology

, Volume 29, Issue 9, pp 1633–1636 | Cite as

Arterial hypertension during treatment with triptorelin in a child with Williams–Beuren syndrome

  • Ekaterini Siomou
  • Chrysoula Kosmeri
  • Maria Pavlou
  • Antonios P. Vlahos
  • Maria I. Argyropoulou
  • Antigoni Siamopoulou
Brief Report

Abstract

Background

Arterial hypertension (AHT) is a common finding in children with Williams–Beuren syndrome (WBS). Although cardiovascular and renal abnormalities can explain the AHT in some patients with WBS, its etiology is not fully understood and most cases are considered idiopathic.

Case-diagnosis/treatment

The case is reported of a 10-year-old girl with WBS who developed severe AHT during treatment with triptorelin, a long-lasting gonadotropin-releasing hormone (GnRH) analog, administered because of early normal puberty. Comprehensive diagnostic studies ruled out other known causes of AHT associated with WBS. After discontinuation of triptorelin, the blood pressure remained within the normal range for her age and height with no antihypertensive treatment on long-term follow-up. To the best of the authors’ knowledge, this is the first report of AHT associated with triptorelin administration in a child with WBS.

Conclusions

Clinicians should be aware of the possibility, although rare, of AHT developing during triptorelin administration in childhood, specifically in patients at increased risk of AHT, such as those with WBS.

Keywords

Williams–Beuren syndrome Arterial hypertension Triptorelin Precocious puberty Gonadotropin-releasing hormone (GnRH) analog 

References

  1. 1.
    Francke U (1999) Williams–Beuren syndrome: genes and mechanisms. Hum Mol Genet 8:1947–1954PubMedCrossRefGoogle Scholar
  2. 2.
    Strømme P, Bjørnstad PG, Ramstad K (2002) Prevalence estimation of Williams syndrome. J Child Neurol 17:269–271PubMedCrossRefGoogle Scholar
  3. 3.
    Pober BR, Johnson M, Urban Z (2008) Mechanisms and treatment of cardiovascular disease in Williams–Beuren syndrome. J Clin Invest 118:1606–1615PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Nicholson WR, Hockey KA (1993) Williams syndrome: a clinical study of children and adults. J Paediatr Child Health 29:468–472PubMedCrossRefGoogle Scholar
  5. 5.
    Bouchireb K, Boyer O, Bonnet D, Brunelle F, Decramer S, Landthaler G, Liutkus A, Niaudet P, Salomon R (2010) Clinical features and management of arterial hypertension in children with Williams–Beuren syndrome. Nephrol Dial Transplant 25:434–438PubMedCrossRefGoogle Scholar
  6. 6.
    Magiakou MA, Manousaki D, Papadaki M, Hadjidakis D, Levidou G, Vakaki M, Papaefstathiou A, Lalioti N, Kanaka-Gantenbein C, Piaditis G, Chrousos GP, Dacou-Voutetakis C (2010) The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab 95:109–117PubMedCrossRefGoogle Scholar
  7. 7.
    Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF Jr, Crawford JD, Crowley WF Jr (1986) Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Endocr Rev 7:24–33PubMedCrossRefGoogle Scholar
  8. 8.
    Calcaterra V, Mannarino S, Corana G, Codazzi AC, Mazzola A, Brambilla P, Larizza D (2013) Hypertension during therapy with triptorelin in a girl with precocious puberty. Indian J Pediatr 80:884–885PubMedCrossRefGoogle Scholar
  9. 9.
    Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W (1997) Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130:178–184PubMedCrossRefGoogle Scholar
  10. 10.
    Partsch CJ, Japing I, Siebert R, Gosch A, Wessel A, Sippell WG, Pankau R (2002) Central precocious puberty in girls with Williams syndrome. J Pediatr 141:441–444PubMedCrossRefGoogle Scholar
  11. 11.
    Cherniske EM, Sadler LS, Schwartz D, Carpenter TO, Pober BR (1999) Early puberty in Williams syndrome. Clin Dysmorphol 8:117–121PubMedGoogle Scholar
  12. 12.
    Del Campo M, Antonell A, Magano LF, Muñoz FJ, Flores R, Bayés M, Pérez Jurado LA (2006) Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension. Am J Hum Genet 78:533–542PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Albaladejo Blanco C, García Vicente JA, García-Faria Rialp F (2004) Hypertension crisis as a side effect of triptorelin? Aten Primaria 34:566–567PubMedCrossRefGoogle Scholar
  14. 14.
    Acs N, Székács B, Nádasy GL, Várbíró S, Kakucs R, Monos E (1999) The effect of ovariectomy and oestrogen replacement on small artery biomechanics in the rat. Br J Obstet Gynaecol 106:148–154PubMedCrossRefGoogle Scholar
  15. 15.
    Várbíró S, Vajó Z, Nádasy GL, Monos E, Acs N, Lóránt M, Felicetta JV, Székacs B (2002) Sex hormone replacement therapy reverses altered venous contractility in rats after pharmacological ovariectomy. Menopause 9:122–126PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2014

Authors and Affiliations

  • Ekaterini Siomou
    • 1
  • Chrysoula Kosmeri
    • 1
  • Maria Pavlou
    • 1
  • Antonios P. Vlahos
    • 1
  • Maria I. Argyropoulou
    • 2
  • Antigoni Siamopoulou
    • 1
  1. 1.Departments of PediatricsUniversity Hospital of IoanninaIoanninaGreece
  2. 2.Departments of RadiologyUniversity Hospital of IoanninaIoanninaGreece

Personalised recommendations